- Home
- SWIN vs APLT Comparison
SWIN vs APLT Comparison
Compare SWIN & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWIN
- APLT
- Stock Information
- Founded
- SWIN 2017
- APLT 2016
- Country
- SWIN Hong Kong
- APLT United States
- Employees
- SWIN N/A
- APLT N/A
- Industry
- SWIN
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- SWIN
- APLT Health Care
- Exchange
- SWIN Nasdaq
- APLT Nasdaq
- Market Cap
- SWIN 32.1M
- APLT 37.5M
- IPO Year
- SWIN 2023
- APLT 2019
- Fundamental
- Price
- SWIN $1.71
- APLT $0.35
- Analyst Decision
- SWIN
- APLT Buy
- Analyst Count
- SWIN 0
- APLT 7
- Target Price
- SWIN N/A
- APLT $6.10
- AVG Volume (30 Days)
- SWIN 193.7K
- APLT 2.9M
- Earning Date
- SWIN 06-10-2025
- APLT 05-13-2025
- Dividend Yield
- SWIN N/A
- APLT N/A
- EPS Growth
- SWIN N/A
- APLT N/A
- EPS
- SWIN N/A
- APLT N/A
- Revenue
- SWIN $2,419,000.00
- APLT $265,000.00
- Revenue This Year
- SWIN N/A
- APLT $1,768.13
- Revenue Next Year
- SWIN $61.68
- APLT $332.85
- P/E Ratio
- SWIN N/A
- APLT N/A
- Revenue Growth
- SWIN N/A
- APLT N/A
- 52 Week Low
- SWIN $1.16
- APLT $0.30
- 52 Week High
- SWIN $5.33
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- SWIN 50.70
- APLT 41.78
- Support Level
- SWIN $1.43
- APLT $0.37
- Resistance Level
- SWIN $1.78
- APLT $0.40
- Average True Range (ATR)
- SWIN 0.18
- APLT 0.06
- MACD
- SWIN -0.03
- APLT -0.01
- Stochastic Oscillator
- SWIN 59.68
- APLT 2.00
About SWIN Solowin Holdings
Solowin Holdings Ltd is a investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secured one-stop electronic platform. It is engaged in providing securities related services, investment advisory service, and asset management service to customers. The operations were organized into four reportable segments: securities related services, investment advisory services, corporate consultancy services, and asset management services. It derives maximum revenue from investment advisory services.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.